GlassScriptPhysician profile
Saada Seidu
NPI 1316232861
$13,354.72
in general payments reported to CMS, 2019-2025
10 companies · $687 in 2025
The $687 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.88 · 2021: $35.57 · 2022: $17.12 · 2023: $1,796 · 2024: $11K · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Food and Beverage: $3,323 · Travel and Lodging: $2,951 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Food and Beverage | $3,322.83 |
| Travel and Lodging | $2,950.58 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,696.41 | 2023-2025 | Da Vinci Surgical System |
| Davol INC. | $911.65 | 2023-2025 | Phasix Mesh |
| Becton, Dickinson and Company | $373.49 | 2024-2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $132.57 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Ethicon US, LLC | $99.24 | 2022-2025 | Echelon; Endopath, Stratafix |
| C. R. Bard, INC. & Subsidiaries | $45.46 | 2023 | Arista Ah Flexitip |
| Misonix INC | $35.57 | 2021 | |
| Bioventus LLC | $20.79 | 2023 | |
| Smith+Nephew, INC. | $19.88 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $19.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saada Seidu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.